Wednesday November 25 2009 | Biotechnology feed | All feeds
|
|
EnVivo Pharmaceuticals
Download detailed PDF Members: Mission: to discover and develop small-molecule therapeutics for disorders of the central nervous system (CNS), specifically neurodegenerative diseases, such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, and Spinocerebellar Ataxias.About UsEnVivo Pharmaceuticals was founded in 2001 and currently has 37 FTEs. EnVivo has raised ~$38M in two funding rounds, $14.9M Series A in October 2002 and $23M Series B in September 2004. Investors include scientific founders, Fidelity Bioscience Group, BBBC Investor Group that includes Baylor College of Medicine, and CoGene BioTech Ventures.
This page has been viewed 263 times since April 2007, the link to the organisation's website has been followed 40 times Recent Search Terms used to find this page: Envivo Pharma | EnVivo Pharmaceuticals | EnVivo Pharmaceuticals | envivo pharma investors | envivo | envivo pharmaceuticals founded 2004 | . Search for more companies in Watertown Search for more companies in Massachusetts This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for EnVivo Pharmaceuticals | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|